glp 1 2026 GLP-1 prescription trends through March 2026 Employee Benefits: Managing GLP-1

PlexusDx breaks down the safety profile and monitoring requirements

DPP-4 is a type of enzyme found in the body that is responsible for breaking down hormones that help to regulate blood sugar levels

Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide

The SMSNA periodically receives and publishesguest editorials. The current article was submitted byMia Barnes, a freelance writer and researcher...

a higher expression of GLP-1R was associated with a decreased risk of SA (OR1=0.98 [95% CI 0.961.00], P1=4.55102